IT IS well established that patients with atherosclerotic coronary heart disease have significantly elevated serum lipids.1-4 This is illustrated in figure 1 by the serum cholesterol concentrations of the subjects of the present study.4 Figure 1 also shows that there is a significant decrease in serum cholesterol from decade to decade in the coronary group (regression coefficient, -15.4 ± 3.9 S.E.). This together with the data of others3 suggests that the higher the serum cholesterol level the younger is the age of onset of clinical coronary heart disease. Prospective studies5' 6 also have shown that in healthy men, those who later incur coronary heart disease have significantly elevated serum lipids.
The question now arises whether, in patients who have survived myocardial infarction, there is any relationship between serum lipid levels and prognosis. Certainly, the belief that lowering serum lipids may improve prognosis in patients with atherosclerotic disease is implicit in the use of hypolipidemic regimens such as diet, drugs, and now even surgery. Yet there is still no convincing evidence to support this assumption.
The present study examines the relation between survival and serum lipid levels during a 5to 7-year follow-up in patients surviving myocardial infarction who received no therapy to alter their serum lipids.
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Material and Methods The coronary heart disease group consisted of 120 men, age 31 to 83, with unequivocal evidence of myocardial infarction. None had valvular disease, syphilis, anemia, polycythemia, thromboangiitis obliterans, or polyarteritis nodosa, so that the cause was almost certainly atherosclerosis. Healthy men from the same Veteran population were matched by age to serve as controls. The designation into decades was according to age at the first visit. All men over 70 were considered in the "eighth" decade. The numbers and ages in the two groups are presented in table 1.
The selection of the participants attempted to eliminate variables other than coronary disease and serum lipids that might influence survival. The serum lipids were only determined after selection. Both groups were free from hypertension (pressure persistently above 150/90), conditions commonly associated with secondary hypercholesteremia (diabetes, nephrosis, hypothyroidism), and any serious intercurrent disease. All subjects were ambulatory at home and not on anticoagulant or dietary treatment. In both groups, the total fat consumption was 38 per cent of calories but the controls tended to eat more calories and more milk fat. 8 At the initial visit, comprehensive clinical and laboratory examinations were carried out as previously described.9 Periodic follow--up examinations were done seven times in 12, six times in 10, five times in 22, four times in 33, three times in 15, twice in 12, and once in 16 coronary patients. Each control was seen on two occasions with an interval of approximately 5 years. No subject in either group was lost to follow-up.
Serum lipid determinations were performed on fasting blood specimens at each visit. The coronary patients were seen at least 3 months after infarction to avoid its lowering effect on serum lipids.10 Serum cholesterol was estimated by the method of Sperry and Webb," the Std. Sf lipoprotein fractionations by the technic of de Lalla and Gofman.12 The standard technical errors have been given previously. 13 Free cholesterol and phospholipid were also measured. Since both were highly correlated with total cholesterol (r =0.9 and 0.8, respectively) ,4 it was necessary to relate survival to total cholesterol only.
Survival was estimated by the actuarial or life table method.14 The significance of the dif-ferences of the survival rates between two groups was determined by the normal deviate test. Because survival was being related to serum lipid levels, the starting point for part of this study was the date of the initial examination and serum lipid determination in each subject in 1952-1954; the end of the follow-up was October 15, 1959. Table 2 lists the causes of death in the coronary group. In the fourth to sixth decades, all deaths were due to coronary heart disease and its immediate complications. Of the 22 deaths in the seventh and eighth decades, seven were not due to cardiovascular disease. Thus, survival rates in the older decades are affected by the intrusion of noncoronary deaths.
Causes of Death
In the control group, four subjects died of coronary disease, one in the fifth, one in the seventh, and two in the eighth decade. Six died of noncoronary causes, one in the fifth, one in the seventh, and four in the eighth decade.
Results

Serum Lipids and Lipoproteins
The levels of the serum lipids and lipopro- Survival curves from the initial examination for the coronary patients divided by the mean serum cholesterol of their respective decade. There was no significant (N.S.) diference at any point.
Survival from Date of Initial Exa
Cumulative Survival
The data for the cumulative s entire coronary group, calculated to-month survey of the number I number deceased, are seen in t the first 12 months, only yearly c for the sake of brevity. vival because their curve was consistently above the other. After the tenth month, however, the curves were generally parallel, with no tendency to diverge. Further, it cannot be held that the consistently longer survival of one group over the other, at comparable times, is of additive significance, since it is obvious that the vertical position of each point on a curve is already affected by the preceding points of that curve. The 120 patients were also divided into the 40 with the lowest cholesterol values, the 40 with the highest, and the 40 between. The survival curves of these three divisions, as shown in figure 5 , are also similar.
Finally, the five patients with the highest cholesterol values from each decade were Circulation, Volume XXXI, June 1965 grouped together and compared to the group composed of the five with the lowest values from each decade. Again, there were no important differences in survival.
Survival and Average Total Serum Cholesterol of the Individual Blood cholesterol readings in an individual are variable. To make most efficient use of the data, the average of all available cholesterol readings in each coronary patient was calculated. Before this mean figure for each patient could be related to survival, it was considered necessary to define within the individual, the relationship of cholesterol to age. Regression coefficients of cholesterol on age were calculated, and an analysis of covari- Survival curves from date of initial examination for patients with a first infarct less than and more than 6 months before the initial examination. There were no significant (N.S.) diferences at any point.
examination of the data showed that no bias was introduced by the age trend in cholesterol because the period of follow-up was similar for the groups above and below the mean cholesterol value in each decade. Therefore, the average of all available cholesterol determinations in each individual was obtained. The mean of these averages was determined in each decade and was designated the "mean of means." The survival of those patients whose average cholesterol was above the mean of means for their decade was compared to that of patients below the mean of means. There was no difference.
Survival from Date of First Diagnosis Cumulative Survival
Instead of calculating survival from the date of the initial examination as above, it was calculated from the date of first diagnosis of myocardial infarction. This could be determined accurately in 118 patients. By this method, the 5-year cumulative survival was 79.2 per cent.
Survival and Total Serum Cholesterol
These patients were divided into those above and those below the mean cholesterol of each decade. The survival rates for the two divisions were similar, as shown in figure 6 .
Survival and Interval Between First Diagnosis and Initial Examination
At the time of entry into the study, 100 of Survival curves from date of first infarct for patients with a first infarct less than and more than 6 months before initial examination. The significance of the diferences between the curves are indicated by the p values.
the patients with coronary disease had survived a first infarct for more than 6 months. To eliminate possible bias from the selection of these relatively long survivors, the data of 18 patients who suffered their first infarct less than 6 months before entry were examined separately. The survival of this group from the date of initial examination was not significantly different from the rest, nor was there any difference between the survival of the highand low-cholesterol divisions within ( fig. 7 ). Survival was then calculated from the date of the first infarct. As in figure 8, there was a significantly increased death rate in those who recently had an infarct as compared to longer survivors. This has been noted previously.'1'8 However, the serum lipids of these patients with the poorer prognosis were no different than the others of the same age group.
Survival and Serum Lipoproteins
The relationship between survival and Std. Sf 0-12, 12-20, 20-100, and 100-400 lipoproteins was studied in the same way as survival and serum cholesterol. Survival rate was calculated both from the date of the initial visit ( fig.  9 ) and from the initial myocardial infarction. There were no important differences between the curves above and below the arithmetical mean of any of these lipoprotein fractions.
Circulation, Volume XXXI, June 1965 Because of the criteria of selection for this study,9 the coronary patients could be considered relatively good risks. The 5-year survival of 79 per cent, calculated from date of first infarct, is similar to that of other goodrisk groups in the literature'8-21 and confirms a recent editorial opinion.22 The indifference of survival to the age of the patient, as shown in figure 3 , is similar to the experience of Honey and Truelove19 However, in comparison to life expectancy of healthy insured Canadian men, the ratio of actual to expected deaths was much greater for the younger than for the older coronary patients, as shown in table 5 . Similar comparisons have been made in previous publications.20 '23 Of course this does not indicate more "malignant" disease in the younger patients with coronary heart disease.
The evidence outlined in the introduction suggests that the higher the serum lipid level, the younger is the age of onset of clinical Survival curves from the initial examination for patients divided by the mean serum lipoprotein values for their respective decade. The differences between the curves of each pair are not significant. This apparent paradox may be resolved by a concept that considers atherosclerosis to occur in two stages: preclinical and clinical. In the long, silent preclinical stage, during the first four or five decades of life, higher levels of serum lipids in some way accelerate atherogenesis with progressive narrowing of arterial lumens. The level of the serum lipids is to some extent an individual, life-long, inherited characteristic.24' 25 From personal observations, essential familial hypercholesteremia is frequently evident in childhood. In one example, serum cholesterol, which had been 123 mg. per cent at birth, was 386 mg. per cent by 6 months of age.
The clinical stage of atherosclerosis begins with some complication such as coronary occlusion and myocardial infarction. On the average, it is much shorter, lasting from minutes to several years. The influence of the serum lipid levels on survival becomes insignificant compared to more critical, nonatherogenic factors that come into operation, such as collateral circulation, electrical excitability of the myocardium, and hemorrhage into an atheroma. Also in a stenosed atheromatous artery, slowing and eddying of the blood stream may be a more potent influence on thrombus formation than that postulated for elevated serum lipids.
The literature contains no compelling evidence that serum lipid levels influence prognosis in survivors of myocardial infarction. In a 1-year follow-up of 359 such patients, Jones et al.2 found that those with higher levels of Sf 12-20 lipoproteins suffered a higher recurrence rate. In the same group of patients, it was later reported26 that those who lived beyond 5 years had significantly lower Std. Sf 0-400 lipoproteins than those who died of recurrent infarction. However, deaths from other causes and over-all survival figures were not given. Marmorston et al.27 found no relation between serum lipid levels and survival in patients with coronary heart disease who were treated with estrogens.
Since the present study examined survivors at least 3 months after infarction, the relation of the serum lipid levels to the immediate mortality could not be studied. In this regard, Jones et al. 2 reported that in 49 patients studied within 1 week of an acute infarct, those dying in hospital had significantly higher serum Sf 0-12 lipoprotein levels.
In the present study, no attempt was made to lower serum lipid concentrations and, therefore, it cannot be concluded that lowering serum lipids would not have prolonged survival. Morrison28 described an 8-year mortality of only 44 per cent in 50 survivors of myocardial infarction who followed a low-fat low-cholesterol diet and maintained weight reduction and lower serum lipid levels. In comparison, 50 control patients on unrestricted diet had a 76 per cent mortality. However, uncooperative patients were dropped from the original treatment group and new ones were added, which introduced some bias. Surprisingly, only half the deaths in both groups were due to cardiovascular disease. Lyon et al.26 reported a decrease in recurrence rate and death rate of myocardial infarction in patients who adhered to a low-fat, low-cholesterol diet as compared to those who did not. Unfortunately, deaths from other causes and the over-all survival rate in each group were not presented. Hansen, Geill, and Lund29 described a significantly decreased incidence of thrombotic disease among elderly persons receiving a diet with vegetable oils replacing dairy and meat fats, as compared to control subjects. They did not mention serum lipid levels or over-all mortality rates. In a 5-year study of 50 coronary patients, Oliver and Boyd30 successfully reduced serum cholesterol levels with estrogens but failed to reduce morbidity and mortality. Thus, the available evidence fails to show that lowering serum lipids improves the prognosis of coronary heart disease.
Summary
This study examined life expectancy and serum lipids in 120 men with atherosclerotic coronary heart disease. Five-year survival from onset of infarction was 79 per cent. No relationship could be demonstrated between survival and the level of the total serum cholesterol, Std. Sf 0-12, 12-20, 20-100, and 100-400 lipoproteins. Survival for patients with an infarct less than 6 months before entry into the study was shorter, despite serum lipid levels the same as the remainder of the group.
Although the age of onset of coronary disease is influenced by serum lipid levels, survival subsequent to infarction is not. This paradox suggests that serum lipids affect rate of atherogenesis in the long preclinical stage but in the short clinical stage other factors determine survival.
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